431 related articles for article (PubMed ID: 19592068)
1. Cyclophosphamide removal from water by nanofiltration and reverse osmosis membrane.
Wang L; Albasi C; Faucet-Marquis V; Pfohl-Leszkowicz A; Dorandeu C; Marion B; Causserand C
Water Res; 2009 Sep; 43(17):4115-22. PubMed ID: 19592068
[TBL] [Abstract][Full Text] [Related]
2. Fouling of reverse osmosis and nanofiltration membranes by dairy industry effluents.
Turan M; Ates A; Inanc B
Water Sci Technol; 2002; 45(12):355-60. PubMed ID: 12201123
[TBL] [Abstract][Full Text] [Related]
3. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
Kimura K; Iwase T; Kita S; Watanabe Y
Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
[TBL] [Abstract][Full Text] [Related]
4. Viability of a low-pressure nanofilter in treating recycled water for water reuse applications: a pilot-scale study.
Bellona C; Drewes JE
Water Res; 2007 Sep; 41(17):3948-58. PubMed ID: 17582458
[TBL] [Abstract][Full Text] [Related]
5. Fouling characteristics of NF and RO operated for removal of dissolved matter from groundwater.
Gwon EM; Yu MJ; Oh HK; Ylee YH
Water Res; 2003 Jul; 37(12):2989-97. PubMed ID: 12767302
[TBL] [Abstract][Full Text] [Related]
6. Removal of toxic ions (chromate, arsenate, and perchlorate) using reverse osmosis, nanofiltration, and ultrafiltration membranes.
Yoon J; Amy G; Chung J; Sohn J; Yoon Y
Chemosphere; 2009 Sep; 77(2):228-35. PubMed ID: 19679331
[TBL] [Abstract][Full Text] [Related]
7. Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment.
Radjenović J; Petrović M; Ventura F; Barceló D
Water Res; 2008 Aug; 42(14):3601-10. PubMed ID: 18656225
[TBL] [Abstract][Full Text] [Related]
8. Use of fouling resistant nanofiltration and reverse osmosis membranes for dyeing wastewater effluent treatment.
Myung SW; Choi IH; Lee SH; Kim IC; Lee KH
Water Sci Technol; 2005; 51(6-7):159-64. PubMed ID: 16003974
[TBL] [Abstract][Full Text] [Related]
9. Removal of bisphenol A (BPA) from water by various nanofiltration (NF) and reverse osmosis (RO) membranes.
Yüksel S; Kabay N; Yüksel M
J Hazard Mater; 2013 Dec; 263 Pt 2():307-10. PubMed ID: 23731784
[TBL] [Abstract][Full Text] [Related]
10. Efficiency of RO/NF membranes at the removal of veterinary antibiotics.
Dolar D; Vuković A; Ašperger D; Košutić K
Water Sci Technol; 2012; 65(2):317-23. PubMed ID: 22233911
[TBL] [Abstract][Full Text] [Related]
11. Characterization and effect of biofouling on polyamide reverse osmosis and nanofiltration membrane surfaces.
Khan MM; Stewart PS; Moll DJ; Mickols WE; Nelson SE; Camper AK
Biofouling; 2011 Feb; 27(2):173-83. PubMed ID: 21253926
[TBL] [Abstract][Full Text] [Related]
12. The feasibility of nanofiltration membrane bioreactor (NF-MBR)+reverse osmosis (RO) process for water reclamation: Comparison with ultrafiltration membrane bioreactor (UF-MBR)+RO process.
Tay MF; Liu C; Cornelissen ER; Wu B; Chong TH
Water Res; 2018 Feb; 129():180-189. PubMed ID: 29149673
[TBL] [Abstract][Full Text] [Related]
13. Rejection of emerging organic micropollutants in nanofiltration-reverse osmosis membrane applications.
Xu P; Drewes JE; Bellona C; Amy G; Kim TU; Adam M; Heberer T
Water Environ Res; 2005; 77(1):40-8. PubMed ID: 15765934
[TBL] [Abstract][Full Text] [Related]
14. Toward improved boron removal in RO by membrane modification: feasibility and challenges.
Bernstein R; Belfer S; Freger V
Environ Sci Technol; 2011 Apr; 45(8):3613-20. PubMed ID: 21417224
[TBL] [Abstract][Full Text] [Related]
15. Effect of water matrices on removal of veterinary pharmaceuticals by nanofiltration and reverse osmosis membranes.
Dolar D; Vuković A; Asperger D; Kosutić K
J Environ Sci (China); 2011; 23(8):1299-307. PubMed ID: 22128537
[TBL] [Abstract][Full Text] [Related]
16. Impact of salt accumulation in the bioreactor on the performance of nanofiltration membrane bioreactor (NF-MBR)+Reverse osmosis (RO) process for water reclamation.
Tay MF; Lee S; Xu H; Jeong K; Liu C; Cornelissen ER; Wu B; Chong TH
Water Res; 2020 Mar; 170():115352. PubMed ID: 31812816
[TBL] [Abstract][Full Text] [Related]
17. Treatability of organic fractions derived from secondary effluent by reverse osmosis membrane.
Hu JY; Ong SL; Shan JH; Kang JB; Ng WJ
Water Res; 2003 Nov; 37(19):4801-9. PubMed ID: 14568067
[TBL] [Abstract][Full Text] [Related]
18. Distillery wastewater treatment by the membrane-based nanofiltration and reverse osmosis processes.
Nataraj SK; Hosamani KM; Aminabhavi TM
Water Res; 2006 Jul; 40(12):2349-56. PubMed ID: 16757012
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hospital wastewater effluent by nanofiltration and reverse osmosis.
Beier S; Köster S; Veltmann K; Schröder H; Pinnekamp J
Water Sci Technol; 2010; 61(7):1691-8. PubMed ID: 20371926
[TBL] [Abstract][Full Text] [Related]
20. Removal of natural hormone estrone from secondary effluents using nanofiltration and reverse osmosis.
Jin X; Hu J; Ong SL
Water Res; 2010 Jan; 44(2):638-48. PubMed ID: 19879623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
